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Abstract: Video laryngoscopy (VL) is a well-established technique used in anaesthetising obese patients
who present with higher risks of airway-related difficulties and desaturations due to shorter safe apnoea
periods. However, VL has certain limitations and may fail. We present the Infrared Red Intubation
System (IRRIS), a new technique facilitating glottis identification in severely obese patients undergoing
anaesthesia for bariatric surgery. This single-centre, prospective trial assessed the efficacy of the IRRIS
for VL tracheal intubation in 20 severely obese adult patients undergoing elective bariatric surgery under
general anaesthesia. We assessed the ability of the IRRIS to differentiate the transilluminated glottis
from the oesophagus and laryngeal folds and evaluated the ease of intubation. The average weight in
the investigated patient cohort was 145 ± 29 kg, the suprasternal tissue thickness was 12 ± 4 mm. The
median IQR [range] larynx recognition time was 10 [2–50] s, which was similar to that of lean patients.
The degree of obesity correlated with the duration to achieve optimal laryngoscopic view and complete
the intubation procedure. We achieved successful VL insertion on the first attempt in 13 of 20 cases
(65%), and on the second attempt in 7 cases (35%), emphasising the increased probability of successful
intubation on the first attempt. Tracheal intubation with the IRRIS lasted 50 [IQR 20–100] s. The
lowest SpO2 during intubation was 98 [IQR 83–100] %. Addition of IRRIS to VL insertion facilitated
the intubation of difficult airways in severely obese patients. IRRIS improves the visualization of the
intubation pathway by selectively highlighting the airway entrance and shortens the time to successfully
conclude the intubation procedure.
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BACKGROUND: Video laryngoscopy (VL) is a well-established technique used in 
anaesthetising obese patients who present with higher risks of airway-related difficulties and 
desaturations due to shorter safe apnoea periods. However, VL has certain limitations and may 
fail. We present the Infrared Red Intubation System (IRRIS), a new technique facilitating 
glottis identification in severely obese patients undergoing anaesthesia for bariatric surgery. 
 
METHODS: This single-centre, prospective trial assessed the efficacy of the IRRIS for VL 
tracheal intubation in 20 severely obese adult patients undergoing elective bariatric surgery 
under general anaesthesia. We assessed the ability of the IRRIS to differentiate the 
transilluminated glottis from the oesophagus and  laryngeal folds and evaluated the ease of 
intubation. 
 
RESULTS: The average weight in the investigated patient cohort was 145 ± 29 kg, the 
suprasternal tissue thickness was 12 ± 4 mm. The median IQR [range] larynx recognition time 
was 10 [2-50] s, which was similar to that of lean patients. The degree of obesity correlated 
with the duration to achieve optimal laryngoscopic view and complete the intubation 
procedure. We achieved successful VL insertion on the first attempt in 13 of 20 cases (65%), 
and on the second attempt in 7 cases (35%), emphasising the increased probability of successful 
intubation on the first attempt. Tracheal intubation with the IRRIS lasted 50 [IQR 20-100] s. 
The lowest SpO2 during intubation was 98 [IQR 83-100] %.  
 
CONCLUSION: Addition of IRRIS to VL insertion facilitated the intubation of difficult 
airways in severely obese patients. IRRIS improves the visualization of the intubation pathway 
by selectively highlighting the airway entrance and shortens the time to successfully conclude 
the intubation procedure. 
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 Video laryngoscopy (VL) is a well-established, widespread, and routine practice in 
anaesthesia. It is represented in the ASA Guidelines for Management of the Difficult Airway1 
as well as in the Difficult Airway Society’s guidelines.2  Both guidelines recommend VL as a 
default technique for anticipated difficult airway situations. Obese patients and, even more so, 
the morbidly obese population present a higher risk for airway-related difficulties and 
complications in anaesthesia.3 A meta-analysis claimed that there was a three-fold higher 
incidence of difficult intubation in these patients.4 However, obesity alone is not a strong 
predictor for difficult intubation, and conventional direct laryngoscopy (DL) is suitable in most 
morbidly obese patients.5 Nevertheless, many studies reported that VL required fewer 
intubation attempts than standard DL in these patient categories.6,7,8 By improving the glottic 
view, primary use of VL may increase the probability of a successful intubation on the first 
attempt, thus reducing the risk for hypoxemia and other airway-related morbidities. VL 
enhances the visualisation of the airway anatomy, and allows the intubating and assisting 
personnel to recognize the passage of the tracheal tube. However, a good laryngeal exposure 
does not mean easy introduction of the tracheal tube into the airway. DL is often the standard 
intubation procedure but VL might be chosen for the initial intubation attempt if the patient has 
a recognised increased risk of difficult intubation, or it might be considered as a backup when 
DL fails.9 
 However, VL has certain limitations when performed by less experienced users. Several 
adjunct instruments and helpful manoeuvres have been suggested to improve its 
performance.10,11 A recent alternative approach is retrograde transillumination, in which near-
infrared light is applied on the anterior surface of the neck, which in turn, produces a distinctive 
blinking light within the tracheal lumen on the VL screen.12,13 The technique presented herein, 
which involves the use of the Infrared Red Intubation System (IRRIS) (Guide In Medical, 
Nazareth, Israel), is a recent revival of retrograde transillumination that utilises a scope to 
discriminate the glottis from its surrounding anatomical structures. This is achieved by 
increasing the contrast between the pharyngeal structures (which remain dark) and the 
laryngeal inlet (which becomes highlighted). The IRRIS device is CE-marked and FDA-
approved. It is the size of a matchbox and is placed on the skin of the anterior neck, cranial to 
the sternal notch and caudal to the thyroid cartilage, preferably on the skin covering the 
cricothyroid membrane. The IRRIS is fixed in position with adhesive strips on both sides. 
 Upon activation, the IRRIS emits a specific near-infrared (NIR) light at a wavelength 
between 730 nm and 1000 nm with varying intensity, which penetrates all the tissues of the 
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anterior neck region beneath the device. The novelty of the IRRIS is that it exclusively 
highlights the glottic opening, whereas all other structures remain dark. The emitted light from 
the IRRIS is infrared and therefore invisible to the naked eye. IRRIS can be employed only 
with VL in which no infrared filter is included. The main purpose of this feature is to distinguish 
the airway from the oesophagus as well as from adjacent structures or mucosal folds that could 
represent a ‘false passage’ for the advancement of the tracheal tube. The IRRIS device can be 
used with various commercial VL devices in which the infrared light is not filtered, such as the 
KingVisionTM VL (Ambu A/S, Baltorpbakken 13, 2750 Ballerup, Denmark). 
 The tissue mass that must be transilluminated by the IRRIS is larger in obese patients 
than in lean patients, and it is not yet clear whether this might represent a limitation to the 
applicability and usefulness of this auxiliary technique. The purpose of this study was to assess 
the impact of the IRRIS on the performance of VL in obese patients, in whom the amount of 
tissue that has to be penetrated by the NIR light is far larger than in lean individuals. 
 
Materials and methods 
 From May to July 2018, we recruited 20 thoroughly informed and consenting adult 
patients, who were scheduled for elective laparoscopic bariatric surgery under general 
anaesthesia via tracheal intubation, at the Ponderas Academic Hospital Centre of Excellence 
for Bariatric and Metabolic Surgery in Bucharest, Romania. We employed VL using the 
KingVisionTM with disposable channelled blades under retrograde transillumination with the 
IRRIS device. The study was approved by the Ponderas Hospital research ethics committee 
(Ref. 08/02/2018,), and written informed consent was obtained from all patients prior to their 
enrolment. 
All included patients were classified as obese as defined by the World Health 
Organization (WHO): an excessive accumulation of fat presenting a risk to health, which can 
be quantified by body mass index (BMI). WHO Class 1 obesity is defined as a BMI of 30 to 
35 kg/m2, Class 2 as a BMI of 35 to 40 kg/m2, and Class 3 as a BMI of ≥ 40 kg/m2. WHO Class 
3 was previously termed as ‘morbid’ obesity but has been recently renamed as ‘extreme’ 
obesity. 
 Inclusion criteria were age >18 years and an ASA physical status of 1 to 3. We excluded 
pregnant women, emergency cases, and patients with pre-existing airway pathologies that were 
not obesity-related. We recorded age, weight, height, body mass index (BMI), sex, neck 
circumference (NC), and SpO2 under spontaneous breathing of room air. Using ultrasound 
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(US) imaging, we documented the patients’ neck tissue thickness at the level of the cricothyroid 
membrane and this was measured in millimetres. 
 We scored all patients for prevalence and severity of obstructive sleep apnoea with the 
Anthropometric-Obstructive Sleep Apnoea (A-OSA) score.14 This includes STOP-Bang, BMI, 
neck circumference, body shape index (ABSI), waist circumference, baseline SpO2, and 
expiratory reserve volume (ERV). According to our local hospital protocol, we prescribed 
preoperative CPAP treatment if the A-OSA score was >3. 
 The study was conducted and supervised by one operator who was experienced with 
VL (DG). The airway was managed exclusively by anaesthesiologists with >2 years of 
professional experience and familiarity with the KingVisionTM video laryngoscope. 
 Prior to inducing anaesthesia, an activated IRRIS device was attached to the skin of the 
anterior neck at the level of the cricothyroid membrane and fixed with adhesive strips. The 
cricothyroid membrane was identified by palpation and verified with US. We also employed 
US to measure the tissue thickness above the subglottic region. After confirming a lack of 
discomfort, anaesthesia was commenced according to our local protocol for obese patients 
featuring low opioid dosage.  
All bariatric patients in our clinic were treated according to a low opioid anaesthesia 
protocol. This consists of induction with propofol 2 mg kg-1 lean body weight (LBW), fentanyl 
100 µg, rocuronium 0,8 mg kg-1 LBW, magnesium sulphate 40 mg kg-1 LBW, lidocaine 1,5 
mg kg-1 LBW, dexamethasone 10 mg, ketamine 20 mg, and diclofenac 150 mg. Maintenance 
of anaesthesia was achieved with sevoflurane at 1.0-1.5 age-adjusted MAC and continuous 
infusion of lidocaine, magnesium, and rocuronium according to clinical needs. We applied a 
multimodal non-opioid postoperative analgesia protocol containing paracetamol 2 g, nefopam 
20 mg, and tramadol 100 mg 15 min prior to extubation. Monitoring included a 5-lead ECG 
and measures for heart rate and non-invasive blood pressure. Patients with obstructive sleep 
apnoea (OSA) or obesity hypoventilation syndrome (OHS) were monitored with an arterial 
line. Additional monitoring consisted of pulse oximetry oxygen saturation, end-expiratory 
carbon dioxide (ETCO2), respiratory gases, ventilatory parameters, bispectral index (BIS), and 
repeated assessment of the neuromuscular block. 
Before induction of anaesthesia, every patient was pre-oxygenated with 100% oxygen 
via a tight-fitting facemask, for 5 minutes at tidal volume ventilation, with an elevated upper 
body such that the ear level and sternal notch were horizontally aligned. During the induction 
period, every patient was manually ventilated with CPAP at 10 cm H2O to prolong the available 
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time to secure the airway. Laryngoscopy was initiated after the end-tidal oxygen saturation rose 
above 90%. 
 The intubation was performed using KingVisionTM channelled VL with facilitated 
viewing by retrograde transillumination. 
 The intubating personnel assessed and documented the following parameters: 
1. Percentage of laryngeal view (POGO score). 
2. Visible distinction of illuminated laryngeal structure from non-illuminated 
neighbouring structures and from the oesophagus (yes or no). 
3. Visibility of the glottic entrance according to a subjective visual analogue scale (VAS) 
(from 0 = ‘very poorly visible’ to 10 = ‘very well visible’). 
4. Number of necessary introductions of the laryngoscope into the pharynx to achieve 
success (n). 
5. Time to recognise the illuminated laryngeal inlet after insertion of the VL (s). 
6. Subjective degree of helpfulness of the IRRIS according to a VAS (from 1 = ‘not 
helpful at all’ to 10 = ‘very helpful’). 
7. Subjective degree of credibility of the IRRIS to recognise the correct intubation 
pathway according to a VAS (from 1 = ‘not credible at all’ to 10 = ‘very credible’). 
8. Subjective degree of ease of IRRIS handling on a VAS (from 1 = ‘very difficult’ to 10 
= ‘very easy’). 
For the evaluation of intubation performance, the following parameters were documented: 
1. Success of video laryngoscopic tracheal intubation within 60 s (‘yes’ or ‘no’).  
2. Number of intubation attempts (n). 
3. Time to conclude intubation from inserting the VL until the tracheal tube cuff was 
inflated (s). 
4. Subjective degree of difficulty of intubation according to a VAS (from 1 = ‘very easy’ 
to 10 = ‘extremely difficult’). 
5. In the case of intubation failure: the necessity of employing an alternative airway 
securing method or aborting tracheal intubation if initial attempt(s) with the IRRIS 
failed (number and choice of alternative techniques).  
After successful tracheal intubation, the IRRIS device was removed and discarded. 
 Maintenance and emergence from anaesthesia were conducted according to our local 
protocol and the individual needs of the patient and surgery. Post-operative assessments of the 
frontal neck’s skin condition were performed at 3 periods following removal of the IRRIS 
device: immediately after removal, 2 hours post-removal, and on the day after surgery. 
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Data were collected in an electronic spreadsheet that enabled descriptive statistical analysis. 
Incomplete data were excluded from the analysis. The results are presented as the mean and 
standard deviation or as the median and interquartile ranges, as appropriate. Normality of data 
distribution was tested using the Shapiro-Wilk test. Categorical data were reported as 





 In our cohort, the average BMI was 48 ± 10 kg/m2. Both neck circumference (48 ± 5 
cm) and midline subglottic tissue thickness (12 ± 4 mm) were typical for these categories 
(Table 1). 
 The functionality and performance of video laryngoscopy with the addition of 
retrograde transillumination (IRRIS) resulted in successful intubation in the majority of cases. 
The details are summarised in Table 2. In two cases, in which the blinking was not visible on 
the VL display, the reason was attributed to the limitations imposed by the channelled 
KingVisionTM VL. The encountered problems were related to difficulties to introduce the VL 
into the mouth and consequently to obtain an adequate image on VL screen. These failures 
cannot be attributed to the functionality of the IRRIS devices.  
 The performance of the tracheal intubations was highly dependent on the quality of the 
obtained laryngoscopic exposure. Thirteen intubations succeeded on the first attempt, while 7 
others could only be completed during a second attempt. The duration to finalise the intubation 
procedure - from the insertion of the laryngoscope into the mouth until the tracheal tube was 
declared to be in place - lasted, on average, under one minute. In one case, the duration to 
successful intubation lasted 180 s, and this case stood out as the most difficult airway case in 
the investigated cohort (Table 3).  
 We found that the degree of obesity correlated with both the time to achieve the best 
possible laryngoscopic view and the time to conclude the intubation procedure. We found a 
clear linear correlation of these two parameters with BMI as well as tissue thickness (Figure 
1). 
 During laryngoscopy and intubation, oxygenation was continuously monitored via 
pulse-oximetry which signalled when airway manipulation had to be interrupted and when it 
was imperative to resume face mask ventilation (Table 4). Except for 3 patients, the 
maintenance of normal oxygen saturation was possible throughout the entire procedure. While 
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the saturation remained unchanged in 12 patients, it increased above the baseline in 5 patients 
and dropped below the baseline in 3 patients. The lowest oxygen saturation (83%) was 
observed in the patient with the most difficult intubation, and after 180 s, intubation was 
successfully completed and normal saturation was restored. 
 
Discussion 
 Our study evaluates the addition, feasibility, and performance of the novel IRRIS device 
for retrograde transillumination, which can be used in conjunction with VL individuals with 
obesity undergoing bariatric surgery present a higher risk of airway-related difficulties and 
anaesthesia-related complications than lean individuals.3,4,5 By providing a better view of the 
airway anatomy and the passageway of the tracheal tube, the primary employment of VL in 
obese patients with suspected airway difficulties may increase the probability of successful 
intubation on the first attempt and thus reduce the risk of hypoxemia and other airway-related 
morbidities.5,8,17,18  
 The IRRIS projects near-infrared light into the tissue of the anterior neck and produces 
a distinctive blinking from within the tracheal lumen that can be viewed on the VL screen12,13. 
We found this approach particularly useful in obese patients because the IRRIS exclusively 
highlights the glottic opening, distinguishing the airway from the oesophagus as well as from 
adjacent structures or mucosal folds which are more prominent in obese patients. Such folds 
can mimic a false passage for the advancement of the tracheal tube, increase the risk of injury, 
and might delay the successful conclusion of tracheal intubation. 
Our results suggest that in most obese patients (18 of 20), IRRIS provided the expected 
visual appearance of the correct intubation pathway on the VL screen. Larynx recognition was 
in average achieved on average within 15 s and tracheal intubation could be completed in less 
than one minute (Table 2). The subjective assessment on handling of the IRRIS device achieved 
in average high scores (7 ± 4 for “helpfulness”, 9 ± 3 for “credibility” and 9.6 ± 1.1 for “ease 
of use”. On the other hand, there was no side effect or problem associated with the use of 
IRRIS. 
 As shown in previous prospective investigations12,13, IRRIS helped in the recognition 
of the right passage for the tracheal tube earlier than DL without this aid. The blinking light 
facilitated the distinction of the glottis from disturbing reflections on the airway mucosa caused 
by the regular light from the VL. Our study answers the question posed in Kristensen’s report12 
as to whether there may be an upper limit in BMI for the usefulness of the IRRIS; for which 
the answer is that we did not identify such a limit. Additionally, we obtained quantitative results 
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for both distinctive parameters - neck circumference and anterior cervical tissue thickness and 
confirmed the ability of the IRRIS to penetrate the abundant anterior neck tissue mass in 
severely obese patients. The two reported cases where the IRRIS light was not visible on the 
VL screen were not related to the IRRIS device itself or to the amount of anterior neck tissue. 
These failures were caused by limitations of the employed VL, where the blades did not match 
the dimensions of the patients’ pharyngeal structures e.g.  it was not possible to introduce the 
VL into the oral cavity and to obtain an image on the VL screen. 
 The time to recognise the illuminated larynx, after passing the teeth with the VL blade, 
was similar in obese and lean patients, even with the inclusion of difficult cases.12,13 Similar to 
Biro et al’s results, the main problems were related to the limitations of the adopted VL. In 
particular, we experienced that most of the intubation time was used to achieve the best possible 
position of the VL blade, which was aggravated by the limited mouth opening and larger tongue 
base in our patients. It was occasionally difficult to lift the epiglottis and bypass abundant 
mucosal structures at the level of the hypopharynx. A review of 20 reported cases in the 
literature of oropharyngeal trauma during VL contains such events with other VL devices as 
well, such as the GlideScope® (Verathon, Inc., Bothell, WA).19 
 Several studies using the GlideScope® have indicated that the ability to view the larynx 
does not correlate with successful intubation because of the marked angle of the blade20. Even 
with a good view of the larynx, the passage of the tube into the trachea may still be difficult.21,22 
The GlideScope® does not require alignment of the three airway axes (oral, pharyngeal, and 
tracheal), and the tracheal tube must be introduced around the curve of the blade.23,24,25,26 To 
overcome this problem, the tracheal tube is often pre‐shaped with a malleable stylet to an angle 
of 60° to 90° that follows the curvature of the GlideScope® blade. Tracheal intubation can cause 
various acute airway injuries including arytenoid subluxation, supraglottic or glottic 
haematoma, laceration of the glottic mucosa and vocal cord, tracheal rupture, and mediastinal 
emphysema.27 
 Retrograde transillumination with the IRRIS showed superior tissue penetration 
compared to other devices such as lighted stylets28 (Davis 2000) which use the ‘light from 
inside out’ method. Therefore, the blind nature of the lightwand technique makes it less suitable 
in cases of airway pathology, friable tissue, and anatomic distortion. In overweight or obese 
patients (i.e., BMI ≥ 25 kg/m2), the intubating time in lightwand-assisted endotracheal 
intubation is significantly increased. Other authors have also reported the failure of lightwand-
assisted intubation in overweight patients.29,30,31,32 Some authors have proposed the use of 
visible light in a retrograde direction (applied through the skin of the anterior neck at the 
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cricothyroid membrane), as a useful technique in patients with normal airway and BMI ≤ 30 
kg/m2, for conventional laryngoscopy and intubation.33,34 Hudson et al. described a retrograde 
trans-tracheal illumination of the glottis, as a rescue technique to facilitate tracheal intubation, 
which uses a flashlight for visualisation of the oropharyngeal structures and glottis, in 
unsuccessful DL cases. Compared with DL, the success rate was greater in the retrograde 
transillumination group for all five intubations (72% vs. 47%; rate difference, 25%; 95% CI 
[11.84–38.16%], P < 0.001). This was associated with a shorter time to glottic exposure in the 
transillumination group (27 s [15; 42] vs. 45 [30; 73] s, P < 0.001), shorter intubation time (66 
[44; 120] vs. 120 [69; 120] s, P < 0.001), and decreased throat soreness.34 All these times were 
longer than those of the IRRIS group. 
 The parameters reflecting the IRRIS performance were distinctly positive. Besides the 
mentioned shorter larynx recognition time, we needed one VL insertion attempt for successful 
viewing in 13 out of 20 cases (65%) and 2 insertion attempts in 7 cases (35%). In accordance 
with other authors, we also emphasise the paramount importance of first-pass success in 
tracheal intubation especially in obese cases due to the increased likelihood of having a short 
safe apnoea period.5,35,36,37,38 
 
Conclusions 
 We conclude that the IRRIS is suitable and useful for retrograde transillumination of 
the larynx in extremely obese patients. If it is used in conjunction with a suitable VL device, 
the larynx becomes more distinguishable on the VL screen and the intubation pathway is 
clearly visualised. This blinking is observed, solely, as coming outward from the trachea, in 
contrast to adjacent structures such as the oesophagus or mucosal folds which remain dark.  
 
 
WHAT IS KNOWN 
• It has been demonstrated that the Infrared Red Intubation System (IRRIS) is a reliable 
technique that facilitates the identification of the glottis and the intubation pathway 
during video laryngoscopy. This has been described in lean patients. 
 
WHAT IS NEW 
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• Our study showed the IRRIS is useful for video laryngoscopic intubation by applying 
retrograde laryngeal transillumination in obese and extremely obese patients such that 
the intubation pathway is clearly visualised on the VL screen.  
• The IRRIS causes blinking from the trachea, as seen on the screen of the video 
laryngoscope, and this clearly distinguishes the airway from the oesophagus and 
adjacent anatomical structures. Even extreme obesity, with a longer distance from the 
skin surface to the tracheal lumen, is no hindrance to the functioning of the retrograde 
transillumination effect. 
• Highlighting the airway during video laryngoscopy may simplify and shorten the 
intubation procedure, thus leading to a higher success rate in securing the airway. In 
particular, obese patients may benefit from a higher first-pass success rate, which might 
reduce morbidity due to desaturation and/or injuries by prolonged manoeuvres to 









1. Apfelbaum JL, Hagberg CA, Caplan RA, Blitt CD, Connis RT, Nickinovich DG, et al. 
Practice guidelines for management of the difficult airway: an updated report by the 
American Society of Anesthesiologists Task Force on Management of the Difficult 
Airway. Anesthesiology 2013;118:251–70. 
2. Frerk C, Mitchell VS, McNarry AF, Mendonca C, Bhagrath R, Patel A, et al. Difficult 
Airway Society 2015 guidelines for management of unanticipated difficult intubation 
in adults. Br J Anaesth 2015;115:827–48. 
3. Juvin P, Lavaut E, Dupont H, Lefevre P, Demetriou M, Dumoulin JL, et al. Difficult 
tracheal intubation is more common in obese than in lean patients. Anesth Analg 
2003;97:595–600. 
 12 
4. Shiga T, Wajima T, Inoue T, Sakamoto A. Predicting Difficult Intubation in 
Apparently Normal Patients: A Meta-analysis of Bedside Screening Test Performance. 
Anesthesiology 2005;103(2):429-37. 
5. Brodsky JB, Lemmens HJ, Brock-Utne JG, Vierra M, Saidman LJ. Morbid obesity and 
tracheal intubation. Anesth Analg 2002;94:732–6. 
6. Yumul R, Elvir-Lazo OL, White PF, Sloninsky A, Kaplan M, Kariger R, et al. 
Comparison of three video laryngoscopy devices to direct laryngoscopy for intubating 
obese patients: a randomized controlled trial. J Clin Anesth 2016;31:71–7. 
7. Fitzgerald E, Hodzovic I, Smith AE. ‘From darkness into light’: time to make awake 
intubation with videolaryngoscopy the primary technique for an anticipated difficult 
airway. Anaesthesia 2015;70:387-92.  
8. Marrel J, Blanc C, Frascarolo P, Magnusson L. Videolaryngoscopy improves 
intubation condition in morbidly obese patients. Eur J Anaesthesiol 2007;24:1045–9.  
9. Lewis SR, Butler AR, Parker J, Cook TM, Smith AF. Videolaryngoscopy versus direct 
laryngoscopy for adult patients requiring tracheal intubation. Cochrane Database Syst 
Rev 2016;15;11:CD011136.    
10. Levitan RM, Mickler T, Hollander JE. Bimanual laryngoscopy: a videographic study 
of external laryngeal manipulation by novice intubators. Ann Emerg Med 2002;40:30–
7.  
11. Hocking G, Roberts FL, Thew ME. Airway obstruction with cricoid pressure and 
lateral tilt. Anaesthesia 2001;56:825–8.  
12. Seltz-Kristensen M, Fried E, Biro P. Infrared Red Intubation System (IRRIS) guided 
flexile videoscope assisted difficult airway management. Acta Anaesthesiol Scand 
2018;62:19–25.  
13. Biro P, Fried E, Seltz-Kristensen M. A new retrograde transillumination technique for 
videolaryngoscopic tracheal intubation. Anaesthesia 2018;73:474–9.  
14. Godoroja D, Sorbello M, Cioc DA. Development and Feasibility of Two Novel Scores 
(DX-OSA and A-OSA) for the Identification of Significant Obstructive Sleep Apnoea 
in Surgical Patients with Obesity. J Anesth Clin Res 2017;8:1–8 
15. Sturm R. Increases in morbid obesity in the USA: 2000–2005. Public Health 
2007;121:492–6.  
16. WHO: Obesity and Overweight [Internet]. World Health Organization; © 2019 [cited 
2017 Oct . Available from: www.who.int/en/news-room/fact-sheets/. 
 13 
17. Aziz MF, Brambrink AM, Healy DW, Willett AW, Shanks A, Tremper T, et al. 
Success of Intubation Rescue Techniques after Failed Direct Laryngoscopy in Adults: 
A Retrospective Comparative Analysis. Anesthesiology 2016;125:656–66. 
18. Murphy C, Wong DT. Airway management and oxygenation in obese patients. Can J 
Anaesth 2013;60:929–45 
19. Greer D, Marshall KE, Bevans S, Standlee A, McAdams P, Harsha W. Review of 
Videolaryngoscopy Pharyngeal Wall Injuries. Laryngoscope 2017;127:349–53.  
20. Su K, Gao X, Xue FS, Ding GN, Zhang Y, Tian M. Subglottic airway injury caused by 
difficult tracheal tube passage. Anaesthesia 2018;72:1291–91. 
21. Bezinover D, Desciak M, Vaida SJ, Pott L. Using a long semirigid catheter with a 
controllable tip to facilitate tracheal intubation with a GlideScope (R). Canadian 
Journal of Anaesthesia 2009;56:775–6. 
22. Cooper RM, Pacey JA, Bishop MJ, McCluskey SA. Early clinical experience with a 
new videolaryngoscope (GlideScope) in 728 patients. Canadian Journal of Anaesthesia 
2005;52: 191–8. 
23. Niforopoulou P, Pantazopoulos I, Demestiha T, Koudouna E, Xanthos T. Video-
laryngoscopes in the adult airway management: a topical review of the literature. Acta 
Anaesthesiol Scand 2010;54:1050–61. 
24. Sun, DA, Warriner, CB, Parsons, DG, Klein, R, Umedaly, HS, Moult, M. The 
GlideScope Video Laryngoscope: randomized clinical trial in 200 patients. Br J 
Anaesth 2005;94:381–4. 
25. Malik MA, O‘Donoghue C, Carney J, Maharaj CH, Harte BH, Laffey JG. Comparison 
of the Glidescope, the Pentax AWS, and the Truview EVO2 with the Macintosh 
laryngoscope in experienced anaesthetists: A manikin study. Br J 
Anaesth. 2009;102:128–34. 
26. Bhola R, Bhalla S, Gupta R, Singh I, Kumar S.Tracheal intubation in patients with 
cervical spine immobilization: A comparison of McGrath® video laryngoscope and 
Truview EVO2®  laryngoscope. Indian J Anaesth 2014;58:269–74. 
27. Xue FS, Liu HP, Liao X, Zhang YM. Measures to facilitate smooth insertion of an 
endotracheal tube into the trachea with GlideScope videolaryngoscopy. Journal of 
Clinical Anaesthesia 2009;21: 381–2. 
28. Davis L, Cook-Sather SD, Schreiner MS. Lighted stylet tracheal intubation: a review. 
Anesth Analg 2000;90:745–56. 
 14 
29. Hung OR1, Pytka S, Morris I, Murphy M, Stewart RD.: II–Clinical trial of a new lightwand 
for tracheal intubation in patients with difficult airways. Can J Anaesth 1995;42:826–
30. 
30. Hung OR1, Pytka S, Morris I, Murphy M, Launcelott G, Stevens S, MacKay W, Stewart RD.. 
Clinical trial of a new lightwand device (Trachlight) to intubate the trachea. 
Anesthesiology 1995;83:509–14. 
31. Nishiyama T, Matsukawa T, Hanaoka K. Optimal length and angle of a new lightwand 
device (Trachlight). J Clin Anesth 1999;11:332–5. 
32. Kim J, Shil Im K, Lee JM,  Ro J,Yoo KY, Kim JB. Relevance of radiological and 
clinical measurements in predicting difficult intubation using light wand (Surch-
liteTM) in adult patients. J Int Med Res 2016;44:136–46. 
33. Hudson J, Vu M, Vu E. Successful intubation using retrograde trans-tracheal 
illumination after laryngoscope light source failure. Br J Anaesth 2010;105:96–7. 
34. Yang T, Hou J, Li J, Zhang X, Zhu X, Ni W, et al. Retrograde light-guided 
laryngoscopy for tracheal intubation: clinical practice and comparison with 
conventional direct laryngoscopy. Anesthesiology 2013;118:1059–64. 
35. Sakles JC, Chiu S, Mosier J, Walker C, Stolz U. The Importance of First Pass Success 
When Performing Orotracheal Intubation in the Emergency Department, Acad Emerg 
Med 201;20:71–78. 
36. Jense HG, Dubin SA, Silverstein PI, O'Leary-Escolas U. Effect of obesity on duration 
of apnea in anesthetized humans. Anesth Analg 1991;72:89–9. 
37. Weingart SD, Levitan, RM Preoxygenation and Prevention of Desaturation During 
Emergency Airway Management. Ann Emerg Med 2012;59:165–75. 
38. Petrini F, Di Giacinto I, Cataldo R, Esposito C, Pavoni V, Donato P, et al. Obesity 
Task Force for the SIAARTI Airway Management Study Group. Perioperative and 
periprocedural airway management and respiratory safety for the obese patient: 2016 





Conflicts of interest 
Peter Biro is Medical Adviser in Guide In Medical (Nazareth, Israel). 
 15 
The authors DG, CC, MA certify that there is no conflict of interest with any financial 
organization regarding the material discussed in the manuscript. 
 
Contributors-  
DG: Contributed equally with PB to plan the study, performed and supervised the clinical 
investigations, and wrote parts of the manuscript including the final revision of the manuscript.  
CC: Manuscript revision.  
MA: Performed clinical investigations.  
PB: Had the original idea to perform this investigation in a dedicated bariatric surgical unit, 
contributed equally with DG to plan the study, and wrote parts of the manuscript including the 
final revision manuscript. 
  
Acknowledgements- 
We thank Mr. Ariel Shrem (CEO of Guide In Medical (Nazareth, Israel) who assisted in 
providing the study materials including training and consultancy for their use. 
Logistic support was provided from institutional and/or departmental sources in Ponderas 








Table I. Biometric characteristics of the investigated patient population (n = 20).  
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Table II. Functionality and performance of the IRRIS device during video laryngoscopic 




Table III. Intubation performance, using a KingVisionTM video laryngoscope with channelled 












LEGEND FOR THE FIGURE 
 
Figure 1. Linear regressions of laryngoscopy and intubation durations with BMI and tissue 
thickness. The correlation coefficients for video laryngoscopic recognition time was: (1) LR 
Time vs. BMI (Ltime = 0.3375 BMI -1.449) and (2) LR Time vs. tissue thickness (Ltime = 1.214 
Tissue + 0.4593). The correlation coefficients for intubation duration was: (3) Intubation time 
vs. BMI (Itime = 1.036 BMI +5.034) and (4) intubation time vs. tissue thickness (Itime = 1.074 
Tissue + 41.79) 
 
 
